Slayden RA - Search Results

1

Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs.

Barry CE 3rd, Slayden RA, Sampson AE, Lee RE. Barry CE 3rd, et al. Among authors: slayden ra. Biochem Pharmacol. 2000 Feb 1;59(3):221-31. doi: 10.1016/s0006-2952(99)00253-1. Biochem Pharmacol. 2000. PMID: 10609550

2

Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates.

Lee RE, Protopopova M, Crooks E, Slayden RA, Terrot M, Barry CE 3rd. Lee RE, et al. Among authors: slayden ra. J Comb Chem. 2003 Mar-Apr;5(2):172-87. doi: 10.1021/cc020071p. J Comb Chem. 2003. PMID: 12625709

3

The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.

Slayden RA, Barry CE 3rd. Slayden RA, et al. Microbes Infect. 2000 May;2(6):659-69. doi: 10.1016/s1286-4579(00)00359-2. Microbes Infect. 2000. PMID: 10884617 Free article. Review.

4

Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.

Slayden RA, Lee RE, Barry CE 3rd. Slayden RA, et al. Mol Microbiol. 2000 Nov;38(3):514-25. doi: 10.1046/j.1365-2958.2000.02145.x. Mol Microbiol. 2000. PMID: 11069675 Free article.

5

Mycolic acids: structure, biosynthesis and physiological functions.

Barry CE 3rd, Lee RE, Mdluli K, Sampson AE, Schroeder BG, Slayden RA, Yuan Y. Barry CE 3rd, et al. Among authors: slayden ra. Prog Lipid Res. 1998 Jul-Aug;37(2-3):143-79. doi: 10.1016/s0163-7827(98)00008-3. Prog Lipid Res. 1998. PMID: 9829124 Review. No abstract available.

6

The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.

Slayden RA, Barry CE 3rd. Slayden RA, et al. Tuberculosis (Edinb). 2002;82(4-5):149-60. doi: 10.1054/tube.2002.0333. Tuberculosis (Edinb). 2002. PMID: 12464486

7

Mechanisms of isoniazid resistance in Mycobacterium tuberculosis.

Barry CE 3rd, Slayden RA, Mdluli K. Barry CE 3rd, et al. Among authors: slayden ra. Drug Resist Updat. 1998;1(2):128-34. doi: 10.1016/s1368-7646(98)80028-9. Drug Resist Updat. 1998. PMID: 16904399

8

Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.

Mdluli K, Slayden RA, Zhu Y, Ramaswamy S, Pan X, Mead D, Crane DD, Musser JM, Barry CE 3rd. Mdluli K, et al. Among authors: slayden ra. Science. 1998 Jun 5;280(5369):1607-10. doi: 10.1126/science.280.5369.1607. Science. 1998. PMID: 9616124

9

Analysis of the Lipids of Mycobacterium tuberculosis.

Slayden RA, Barry CE 3rd. Slayden RA, et al. Methods Mol Med. 2001;54:229-45. doi: 10.1385/1-59259-147-7:229. Methods Mol Med. 2001. PMID: 21341079

10

Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.

Slayden RA, Lee RE, Armour JW, Cooper AM, Orme IM, Brennan PJ, Besra GS. Slayden RA, et al. Antimicrob Agents Chemother. 1996 Dec;40(12):2813-9. doi: 10.1128/AAC.40.12.2813. Antimicrob Agents Chemother. 1996. PMID: 9124847 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters